# Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease

> **NCT00921128** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Muscimol

## Key facts

- **NCT ID:** NCT00921128
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06-02
- **Primary completion:** —
- **Final completion:** 2016-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00921128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00921128, "Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00921128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*